+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

3D Cell Culture - Global Strategic Business Report

  • PDF Icon

    Report

  • 150 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4804549

Global 3D Cell Culture Market to Reach $3.6 Billion by 2030

The global market for 3D Cell Culture estimated at US$1.4 Billion in the year 2023, is projected to reach a revised size of US$3.6 Billion by 2030, growing at a CAGR of 12% over the analysis period 2023-2030.

Scaffold-based 3D Cell Culture, one of the segments analyzed in the report, is projected to record 12.1% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Scaffold-free 3D Cell Culture segment is estimated at 11.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $498.7 Million, While China is Forecast to Grow at 12.9% CAGR

The 3D Cell Culture market in the U.S. is estimated at US$498.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$248.8 Million by the year 2030 trailing a CAGR of 12.9% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 10.5% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 14.2% CAGR.

Exciting New Report Features

  • Full access to influencer engagement stats
  • Free access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
  • Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
  • Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
  • Complimentary report updates for one year
  • Competitor coverage with global market shares of major players
  • Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
  • Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 38 Featured)

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Corning, Inc.
  • Charles River Laboratories International, Inc.
  • BioTek Instruments, Inc.
  • F. Hoffmann-La Roche AG
  • AMS Biotechnology (Europe) Ltd. (amsbio)
  • BellBrook Labs
  • ABER Instruments Ltd.
  • Creative Biolabs
  • Elveflow
  • Emulate, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Corporate Social Responsibility (CSR) Investments in US$ Billion for the years 2020 through 2027
  • World Market Trajectories
  • 3D Cell Culture - Global Key Competitors Percentage Market Share in 2023 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
  • 3D Cell Culture Transforms Life Sciences Industry
  • 3D Cell Culture: An Introduction
  • 3D-Cell Culture Models
  • Benefits of 3D Cell Culture
  • Key 3D Cell Culture Formats
  • 3D Cell Culture - Different Techniques
  • Scaffold-Based 3D Cell Culture
  • Polymeric Hard Scaffolds
  • Biological Scaffolds
  • Micropatterned Surface Microplates
  • Non-Scaffold Based 3D Cell Culture
  • Hanging Drop Microplates
  • Spheroid Microplates with Ultra-Low Attachment (ULA) coating
  • Microfluidic 3D Cell Culture
  • Expanding Applications Fuel Growth in the Global 3D Cell Culture Market
  • Developed Regions Lead the 3D Cell Culture Market, Asia-Pacific to Register Faster Growth
  • Scaffold-based 3D Cell Culture Products Dominate the Market
  • Cancer and Stem Cell Research Leads the Global Market
  • Competitive Scenario
  • Key Commercial 3D Cell Culture Devices
2. FOCUS ON SELECT PLAYERS
  • Recent Market Activity
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Cancer Drives the Demand for 3D Cell Culture
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Increasing Demand for 3D Cell Culture in Drug Discovery
  • Use of 3D Cell Culture for Regenerative Medicine
  • Organoids as Alternatives to Using Animals in Experiments
  • Use of 3D Cell Culture for Regenerative Medicine
  • Microfluidic Chips Hold Potential in Addressing 3D Cell Culture Challenges
  • Technological Advancements Promote 3D Cell Culture Market
  • Researchers Use Lab-on-a-CD Technology to Generate Spheroid 3D Cell Cultures
  • 3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space
  • A Review of Research Efforts and Achievements of Companies and Universities
  • 3D Tissue Culture: Growing Significance in Cancer Research
  • Cells Grown in 3D Change Cell Proliferation and Morphology
  • Cells Grown in 3D Demonstrate a More Pragmatic Drug Response
  • Cells Grown in 3D Express Phenotypic Heterogeneity
  • Cells Grown in 3D Alter Cell Behavior and Gene Expression
  • Cells Grown in 3D Replicate the Tumor Microenvironment
  • Other Advantages of 3D Tissue Culture Models
  • New Dimension of Cell Culture: The Rise of Spheroid Culture Systems
  • Challenges
  • Progress in Scaffolds and Hydrogels Aids Creation of Organoids and Spheroids
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for 3D Cell Culture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 3: World 13-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2017, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Scaffold-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 6: World 13-Year Perspective for Scaffold-based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Scaffold-free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 9: World 13-Year Perspective for Scaffold-free by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Microfluidics-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 12: World 13-Year Perspective for Microfluidics-based by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Magnetic & Bioprinted by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 15: World 13-Year Perspective for Magnetic & Bioprinted by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Cancer & Stem Cell Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 18: World 13-Year Perspective for Cancer & Stem Cell Research by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Drug Discovery & Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 21: World 13-Year Perspective for Drug Discovery & Toxicology Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Tissue Engineering & Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 24: World 13-Year Perspective for Tissue Engineering & Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2017, 2024 & 2030
  • Table 25: World 3D Cell Culture Market Analysis of Annual Sales in US$ Thousand for Years 2017 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 28: USA 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 29: USA Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 30: USA Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 31: USA 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
CANADA
  • Table 32: Canada Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 34: Canada 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 35: Canada Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: Canada Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 37: Canada 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
JAPAN
  • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 38: Japan Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 40: Japan 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 41: Japan Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: Japan Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 43: Japan 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
CHINA
  • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 44: China Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 46: China 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 47: China Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 48: China Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 49: China 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
EUROPE
  • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 50: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for 3D Cell Culture by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 52: Europe 13-Year Perspective for 3D Cell Culture by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2017, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 55: Europe 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 56: Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 58: Europe 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
FRANCE
  • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 59: France Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 61: France 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 62: France Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: France Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 64: France 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
GERMANY
  • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 65: Germany Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 67: Germany 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 68: Germany Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: Germany Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 70: Germany 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
ITALY
  • Table 71: Italy Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 73: Italy 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 74: Italy Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: Italy Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 76: Italy 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
UNITED KINGDOM
  • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 77: UK Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 79: UK 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 80: UK Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: UK Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 82: UK 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
REST OF EUROPE
  • Table 83: Rest of Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 84: Rest of Europe Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 85: Rest of Europe 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 86: Rest of Europe Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: Rest of Europe Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 88: Rest of Europe 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
ASIA-PACIFIC
  • 3D Cell Culture Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 90: Asia-Pacific Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 91: Asia-Pacific 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 92: Asia-Pacific Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Asia-Pacific Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 94: Asia-Pacific 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
REST OF WORLD
  • Table 95: Rest of World Recent Past, Current & Future Analysis for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of World Historic Review for 3D Cell Culture by Product - Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 97: Rest of World 13-Year Perspective for 3D Cell Culture by Product - Percentage Breakdown of Value Revenues for Scaffold-based, Scaffold-free, Microfluidics-based and Magnetic & Bioprinted for the Years 2017, 2024 & 2030
  • Table 98: Rest of World Recent Past, Current & Future Analysis for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 99: Rest of World Historic Review for 3D Cell Culture by Application - Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2017 through 2022 and % CAGR
  • Table 100: Rest of World 13-Year Perspective for 3D Cell Culture by Application - Percentage Breakdown of Value Revenues for Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing and Tissue Engineering & Regenerative Medicine for the Years 2017, 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • GE Healthcare
  • Corning, Inc.
  • Charles River Laboratories International, Inc.
  • BioTek Instruments, Inc.
  • F. Hoffmann-La Roche AG
  • AMS Biotechnology (Europe) Ltd. (amsbio)
  • BellBrook Labs
  • ABER Instruments Ltd.
  • Creative Biolabs
  • Elveflow
  • Emulate, Inc.